Skip to Main Content

An official website of the United States government

Here you can browse the complete list of publications for studies listed on CDAS.

Publication Year
Title PubMed Authors Journal Year Studies
Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National Lung Screening Trial. 25065710 Gareen IF, Duan F, Greco EM, Snyder BS, Boiselle PM, Park ER, Fryback D, Gatsonis C Cancer 2014 NLST
Bladder cancer risk: Use of the PLCO and NLST to identify a suitable screening cohort. 25044253 Krabbe LM, Svatek RS, Shariat SF, Messing E, Lotan Y Urol. Oncol. 2014 NLST, PLCO
Comparing benefits from many possible computed tomography lung cancer screening programs: extrapolating from the National Lung Screening Trial using comparative modeling. 24979231 McMahon PM, Meza R, Plevritis SK, Black WC, Tammemagi CM, Erdogan A, ten Haaf K, Hazelton W, Holford TR, Jeon J, Clarke L, Kong CY, Choi SE, Munshi VN, Han SS, van Rosmalen J, Pinsky PF, Moolgavkar S, de Koning HJ, Feuer EJ PLoS ONE 2014 NLST
CT screening for lung cancer: alternative definitions of positive test result based on the national lung screening trial and international early lung cancer action program databases. 24955929 Yip R, Henschke CI, Yankelevitz DF, Smith JP Radiology 2014 NLST
Impact of lung cancer screening results on smoking cessation. 24872540 Tammemägi MC, Berg CD, Riley TL, Cunningham CR, Taylor KL J. Natl. Cancer Inst. 2014 NLST
Short- and long-term lung cancer risk associated with noncalcified nodules observed on low-dose CT. 24755313 Pinsky PF, Nath PH, Gierada DS, Sonavane S, Szabo E Cancer Prev Res (Phila) 2014 NLST
Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials. 24577803 Meza R, ten Haaf K, Kong CY, Erdogan A, Black WC, Tammemagi MC, Choi SE, Jeon J, Han SS, Munshi V, van Rosmalen J, Pinsky P, McMahon PM, de Koning HJ, Feuer EJ, Hazelton WD, Plevritis SK Cancer 2014 NLST, PLCO
Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. 24379002 de Koning HJ, Meza R, Plevritis SK, ten Haaf K, Munshi VN, Jeon J, Erdogan SA, Kong CY, Han SS, van Rosmalen J, Choi SE, Pinsky PF, Berrington de Gonzalez A, Berg CD, Black WC, Tammemägi MC, Hazelton WD, Feuer EJ, McMahon PM Ann. Intern. Med. 2014 NLST
A qualitative study of lung cancer risk perceptions and smoking beliefs among national lung screening trial participants. 23999653 Park ER, Streck JM, Gareen IF, Ostroff JS, Hyland KA, Rigotti NA, Pajolek H, Nichter M Nicotine Tob. Res. 2014 NLST
Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts. 25460915 Tammemägi MC, Church TR, Hocking WG, Silvestri GA, Kvale PA, Riley TL, Commins J, Berg CD PLoS Med. 2014 NLST, PLCO
Cost-effectiveness of CT screening in the National Lung Screening Trial. 25372087 Black WC, Gareen IF, Soneji SS, Sicks JD, Keeler EB, Aberle DR, Naeim A, Church TR, Silvestri GA, Gorelick J, Gatsonis C, National Lung Screening Trial Research Team N. Engl. J. Med. 2014 NLST
Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination. 25326638 Gierada DS, Pinsky P, Nath H, Chiles C, Duan F, Aberle DR J. Natl. Cancer Inst. 2014 NLST
Analysis of serial ovarian volume measurements and incidence of ovarian cancer: implications for pathogenesis. 25217774 Bodelon C, Pfeiffer RM, Buys SS, Black A, Sherman ME J. Natl. Cancer Inst. 2014 PLCO
Abnormal CA-125 levels in menopausal women without ovarian cancer. 25127988 Terada KY, Elia J, Kim R, Carney M, Ahn HJ Gynecol. Oncol. 2014 PLCO
Interval lung cancers not detected on screening chest X-rays: How are they different? 25123333 Kvale PA, Johnson CC, Tammemägi M, Marcus PM, Zylak CJ, Spizarny DL, Hocking W, Oken M, Commins J, Ragard L, Hu P, Berg C, Prorok P Lung Cancer 2014 PLCO
Non-compliance with the initial screening exam visit in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. 25038532 Marcus PM, Ogden SL, Gren LH, Childs JC, Pretzel SM, Lamerato LE, Walsh K, Rozjabek HM, Mabie J, Thomas B, Riley T Prev Med 2014 PLCO
Diabetes and pancreatic cancer survival: a prospective cohort-based study. 24786605 Toriola AT, Stolzenberg-Solomon R, Dalidowitz L, Linehan D, Colditz G Br. J. Cancer 2014 PLCO
Modified Gleason grade of prostatic adenocarcinomas detected in the PLCO cancer screening trial. 24594407 Humphrey PA, Hickey TP, Riley TL, Mabie JE, Bellinger A, Strother M, Andriole GL J. Urol. 2014 PLCO
Serum immunoglobulin e and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. 24718282 Olson SH, Hsu M, Wiemels JL, Bracci PM, Zhou M, Patoka J, Reisacher WR, Wang J, Kurtz RC, Silverman DT, Stolzenberg-Solomon RZ Cancer Epidemiol. Biomarkers Prev. 2014 PLCO
Germline variation in NCF4, an innate immunity gene, is associated with an increased risk of colorectal cancer. 23982929 Ryan BM, Zanetti KA, Robles AI, Schetter AJ, Goodman J, Hayes RB, Huang WY, Gunter MJ, Yeager M, Burdette L, Berndt SI, Harris CC Int. J. Cancer 2014 PLCO